Burrage Capital Management
Latest statistics and disclosures from Burrage Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Amr, and represent % of Burrage Capital Management's stock portfolio.
- Added to shares of these 1 stock: Amr.
- Started 1 new stock position in Amr.
- Reduced shares in these 10 stocks: , NTLA (-$10M), Epizyme (-$7.0M), EPIX (-$6.8M), NEO (-$6.7M), , CRNX (-$5.6M), CYTK, , HRMY.
- Sold out of its positions in FOLD, AVRO, BCRX, BDTX, CRNX, CYTK, Epizyme, EPIX, G1 Therapeutics, GERN. HRMY, INZY, NTLA, Mei Pharma, MIRM, NEO, RVMD, Turning Point Therapeutics I, Verastem, YMAB, ADCT, MRUS.
- Burrage Capital Management was a net seller of stock by $-100M.
- Central Index Key (CIK): 0001796461
Tip: Access up to 7 years of quarterly data
Positions held by Burrage Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 1 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| 0 0 | 0.0 | $0 | NEW | 0 | 0.00 |
|
Past Filings by Burrage Capital Management
SEC 13F filings are viewable for Burrage Capital Management going back to 2019
- Burrage Capital Management 2021 Q3 filed Nov. 15, 2021
- Burrage Capital Management 2021 Q2 filed Aug. 16, 2021
- Burrage Capital Management 2021 Q1 filed May 17, 2021
- Burrage Capital Management 2020 Q4 filed Feb. 12, 2021
- Burrage Capital Management 2020 Q3 filed Nov. 13, 2020
- Burrage Capital Management 2020 Q2 filed Aug. 14, 2020
- Burrage Capital Management 2020 Q1 filed May 14, 2020
- Burrage Capital Management 2019 Q4 filed Feb. 14, 2020